170266 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses Togaviridae; Flaviviridae
Sub-classes:METHODS AND REAGENTS FOR ZIKA VIRUS IMMUNOASSAYS
#2RAPID DETECTION AND ANALYSIS OF BIOLOGICAL COMPONENTS USING SURFACE ENHANCED RAMAN SPECTROSCOPY
#3Methods and compositions for assessing antibody specificities
#4SYSTEM AND METHODS FOR DETECTION OF PATHOGENIC VIRUSES
#5Methods and compositions for assessing antibody specificities
#6METHODS AND REAGENTS FOR ZIKA VIRUS IMMUNOASSAYS
#7Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e
#8Methods and reagents for Zika virus immunoassays
#9Human zika virus antibodies and methods of use therefor
#10Methods and compositions for assessing antibody specificities
#11METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#12RECOMBINANT BACULOVIRUSES AND THEIR USES IN DETECTING ARTHROPOD-BORNE VIRUS
#13METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT
#14Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#15Human Zika virus antibodies and methods of use therefor
#16Recombinant baculoviruses and their uses in detecting arthropod-borne virus
#17Multiplex immuno screening assay
#18Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#19Multiplex immuno screening assay
#20Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
#21Multiplex immuno screening assay
#22Drug target and construct for Japanese encephalitis virus infection
#23Molecular imprinting of West Nile antibodies with physiological pH matching
#24Pestivirus species
#25Protease-based biosensor
#26Multiplex immuno screening assay
#27Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
#28Pestivirus species
#29Identification of conserved peptide blocks in homologous polypeptides
#30JFH-1 based HCV cell culture systems for NS5A of genotypes 1-7
#31FLAVIVIRUS SPECIES-SPECIFIC PEPTIDE TAGS FOR VACCINE AND DIAGNOSTIC USE
#32Pestivirus species
#33Compositions and methods for identifying response targets and treating flavivirus infection responses
#34Polynucleotide derived from novel hepatitis C virus strain and use thereof
#35Attenuated pestiviruses
#36Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#37Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
#38ANALYSIS OF HCV GENOTYPES
#39HCV-derived polypeptides and uses thereof
#40HUMANIZED ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF
#41Method for Identifying Inhibitors Against Dengue Virus
#42Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#43Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form
#44Hepatitis-C virus testing
#45METHODS FOR DETECTION OR MEASUREMENT OF VIRUSES
#46Antibody binding to envelope protein 2 of hepatitis C virus and method for identifying genotype of hepatitis C virus using the same
#47ANALYTICAL METHOD FOR THE DETECTION OF LATENT HEPATITIS C, USE THEREOF AND CORRESPONDING DIAGNOSIS KIT
#48Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
#49Anti-chikungunya monoclonal antibodies and uses thereof
#50Composition for treating virus infection disease comprising Jab1
#51HCV NS3-NS4 Protease Resistance Mutants
#52HIGH THROUGHPUT PROTEIN INTERACTION ASSAY
#53Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C
#54Peptide Derived from Hepatitis C Virus
#55Hepatitis-C virus testing
#56METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS
#57Pestivirus species
#58METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION
#59Methods and compositions for inhibition of viral replication
#60Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
#61Infectious, Chimeric Hepatitis C Virus, Methods of Producing the Same and Methods of Use Thereof
#62Methods and reagents for the analysis and purification of polysaccharides
#63PATHOGEN BINDING
#64COMPETITIVE ENZYME LINKED IMMUNOSORBENT ASSAY (C-ELISA) FOR THE DETECTION OF A FLAVIVIRUS SPECIFIC ANTIBODY
#65Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
#66IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO
#67Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
#68Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
#69Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#70INSTALLATION AND METHOD FOR THE PURIFICATION OF AN AQUEOUS EFFLUENT BY MEANS OF OXIDATION AND MEMBRANE FILTRATION
#71Isolation of Inhibitors of IRES-Mediated Translation
#72Early detection of flaviviruses using the NS1 glycoprotein
#73Method to measure and characterize microvesicles in the human body fluids
#74HCV NS3-NS4 protease resistance mutants
#75Methods and compositions for inhibition of viral replication
#76Compositions and Methods for Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes
#77Methods of diagnosing, preventing and treating infection with Hepatitis C virus
#78Early detection of flaviviruses using the NS1 glycoprotein
#79Detection of bovine viral diarrhea virus in tissue samples
#80Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
#81Method for inducing an immunological response in an animal
#82Compositions and methods for identifying response targets and treating flavivirus infection responses
#83Compositions and methods related to flavivirus envelope protein domain III antigens
#84Hepatitis-C virus type 4, 5 and 6
#85Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism
#86Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
#87Human monoclonal antibody Fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity
#88REAGENT KIT AND METHOD FOR MEASURING HCV ANTIBODY
#89Antigen of Dengue Virus Type 1
#90HCV RNA-dependent RNA polymerase
#91IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO HCV-796, AND METHODS RELATED THERETO
#92Method of screening compound preventing cells from infection with Hepatitis C virus (HCV)
#93Determination of risk of developing dengue hemorrhagic fever/dengue shock syndrome, methods and compositions therefor
#94Composition for Treating Virus Infection Disease Comprising Jab1
#95Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes
#96Method of detecting hepatitis C virus
#97FLAVIVIRUS PROTEASE SUBSTRATES AND INHIBITORS
#98Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
#99Livestock health management
#100Purified active HCV NS2/3 protease
#101Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence
#102Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
#103Hepatitis-C virus type 4, 5 and 6
#104Purified active HCV NS2/3 protease
#105HCV RNA-dependent RNA polymerase
#106Dengue virus detection measured by immunocytometry in a dendritic cell surrogate
#107Method for the measurement of dengue virus binding inhibition
#108Hepatitis-C virus testing
#109Binding molecules capable of neutralizing West Nile virus and uses thereof
#110Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
#111Immunogenic reagents from west nile virus
#112Attenuated dengue virus comprising mutations in the NS3 gene
#113Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences
#114Assay
#115METHODS AND REAGENTS FOR THE ANALYSIS AND PURIFICATION OF POLYSACCHARIDES
#116Non-human mammal model comprising heterologous nucleated cells - use for screening compounds
#117Binding molecules capable of neutralizing west nile virus and uses thereof
#118HCV polymerase suitable for crystal structure analysis and method for using the enzyme
#119Protease regulator screening assay
#120PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM
#121FBL2-specific agents as modulators of Flaviviridae RNA replication
#122Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
#123Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
#124Methods and compositions for identifying anti-HCV agents
#125Method for screening compounds against by using persistent virus-infected cell system
#126Hepatitis C virus E2 binding protein
#127Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells
#128Method for inducing complete hepatitis c virus (hcv) replication in vitro
#129Set of ubiquitous cellular proteins involved in viral life cycle
#130Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof
#131Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof
#132Human hepatic progenitor cells and methods of use thereof
#133Attenuated pestiviruses
#134Drug discovery method
#135Subunit vaccine against West Nile viral infection
#136Hepatitis C virus constructs characterized by high efficiency replication
#137Gb virus b based replicons and replicon enhanced cells
#138Diagnostic reagent for hepatitis C virus infection
#139Hepatitis-C virus type 4, 5 and 6
#140Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form
#141Hepatitis C virus assay systems
#142Nucleic acids encoding chimeric immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence
#143HCV NS3-NS4A protease resistance mutants
#144Single cell assessment of viral infection/replication
#145Hepatitis
#146Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
#147Cellular regulators of infectious agents and methods of use
#148Detection of West Nile virus infection and vaccination
#149Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
#150Monitoring immunologic, hematologic and inflammatory diseases
#151Hepatitis-C virus type 4, 5, and 6
#152Screening for hepatitis c virus entry inhibitors
#153Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#154Propagation of human hepatocytes in non-human animals
#155Attenuated pestiviruses